P. Lee
Duke University · 7 works · 8 citations · h-index 1
Top works
- A multicenter, nonrandomized, open-label, single-arm phase 2 trial of dovitinib (TKI258) as second-line therapy in patients with fibroblast growth factor receptor 2-mutated or wild-type advanced and/or metastatic endometrial cancer
- Addressing comfort-care in the ambulatory setting is associated with im- proved end-of-life quality measures among women with ovarian cancer
- Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer
- Abstract 13: Cost effectiveness of early palliative care intervention in recurrent platinum resistant ovarian cancer
- Cost-effectiveness of early palliative care intervention in recurrent plati- num-resistant ovarian cancer
- Palliative surgical procedures in the last 6months of life: Effect on quality care measures